Results 141 to 150 of about 225,397 (165)

Risk factors of prevention of Graves' ophthalmopathy

open access: yes, 2003
TANDA, MARIA LAURA PIERA   +2 more
core  

Outcome and Safety of Different Cumulative Doses and Protocols of Intravenous Methylprednisolone in Moderate to Severe and Active Graves’ Ophthalmopathy

Ophthalmologica Indonesiana, 2019
Background: Graves’ ophthalmopathy (GO), also known as Graves’ orbitopathy or thyroid eye disease, has a potential sight-threatening complications. The activity and severity are important determinants in GO and are implications for treatment. Intravenous Glucocorticoid (GC) was associated with significantly greater efficacy and
Amelya Permata Sari   +2 more
openaire   +1 more source

Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy

International Journal of Molecular Sciences, 2022
Huasheng Yang   +2 more
exaly  

Graves’ ophthalmopathy: a rational approach to treatment

Trends in Endocrinology and Metabolism, 2002
Mark F Prummel
exaly  

Cytokines in the Evolution of Graves' Ophthalmopathy

Autoimmunity, 1997
Neena Natt, R S Bahn
exaly  

Home - About - Disclaimer - Privacy